Clinical Trial Update: Prevention of Thrombocytopenia in Glioblastoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing strategies to prevent thrombocytopenia in glioblastoma patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Thrombocytopenia

Snippet

Sponsor: University Hospital, Lille | Conditions: Thrombocytopenia, Glioblastoma | Phase 2 | Status: TERMINATED